HB 1239 Enacted
Opioids - As enacted, clarifies that a physician licensed in this state is the only healthcare provider authorized to prescribe a buprenorphine product for a FDA-approved use in recovery or medication-assisted treatment; revises criteria for providers not licensed in this state to prescribe a buprenorphine product for the treatment of opioid use disorder. - Amends TCA Title 33; Title 41; Title 53 and Title 63.
Introduced
In Committee
Floor
Crossed Over
Passed
Enacted
No summary has been published for this bill. The full text is on the Bill text tab.
- Chamber
- House
- Introduced
- Feb 6, 2025
- Last action
- Apr 28, 2025 — Pub. Ch. 295
- Session
- 114
- Momentum
- 84 · Very high